McKesson (MCK) Financials: History & Chart

McKesson Corporation (MCK)MCKMcKesson Corporation

About McKesson Corporation

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Irving, TX

43,000 employees

www.mckesson.com

Healthcare / Medical - Distribution

Sector: Healthcare
Industry: Medical - Distribution
CEO: Brian S. Tyler

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024	Quarter ended Jun 2024
Revenue	403.43B	96.30B	106.16B	103.15B	97.83B	90.82B	95.29B	93.65B	79.28B
Cost of Goods Sold	388.88B	92.25B	102.47B	99.61B	94.55B	87.90B	92.07B	90.50B	76.33B
Gross Profit	14.55B	4.04B	3.69B	3.54B	3.28B	2.92B	3.22B	3.15B	2.96B
Gross Profit Margin	3.6%	4.2%	3.5%	3.4%	3.4%	3.2%	3.4%	3.4%	3.7%
Total Operating Expenses	8.18B	1.80B	2.07B	2.07B	2.24B	1.88B	1.93B	2.40B	1.90B
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	4.04B	1.80B	-2.03B	2.07B	2.20B	1.88B	1.93B	2.40B	1.90B
Operating Income (EBIT)	6.37B	2.25B	1.62B	1.47B	1.04B	1.04B	1.29B	745.00M	1.06B
Operating Margin	1.6%	2.3%	1.5%	1.4%	1.1%	1.1%	1.4%	0.8%	1.3%
Income Before Tax (EBT)	6.20B	2.13B	1.63B	1.40B	1.05B	1.51B	1.23B	534.00M	1.08B
Interest Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	125.00M	-61.00M	63.00M	74.00M	49.00M	45.00M	67.00M	78.00M	66.00M
Other Income/Expense	-170.00M	-123.00M	11.00M	-73.00M	15.00M	479.00M	-61.00M	-211.00M	23.00M
Net Income	4.76B	1.68B	1.19B	1.11B	784.00M	1.26B	879.00M	241.00M	915.00M
Income Tax Expense	1.10B	270.00M	380.00M	232.00M	220.00M	209.00M	298.00M	247.00M	124.00M
Net Profit Margin	1.2%	1.7%	1.1%	1.1%	0.8%	1.4%	0.9%	0.3%	1.2%
EBITDA	7.10B	2.44B	1.81B	1.66B	1.19B	1.19B	1.44B	908.00M	1.23B
EBITDA Margin	1.8%	2.5%	1.7%	1.6%	1.2%	1.3%	1.5%	1.0%	1.6%
Depreciation & Amortization	729.00M	196.00M	188.00M	188.00M	157.00M	151.00M	153.00M	163.00M	169.00M
EPS Basic	38.64	13.78	9.63	8.95	6.28	10.06	6.98	1.87	7.05
EPS Diluted	38.47	13.71	9.59	8.92	6.25	10.01	6.94	1.86	7.00
Shares Outstanding	122.10M	122.10M	123.20M	124.00M	124.90M	125.20M	126.00M	128.70M	129.80M
Diluted Shares Outstanding	122.70M	122.70M	123.70M	124.40M	125.50M	125.90M	126.60M	129.30M	130.70M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	03/31/2026	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021	03/31/2020	03/31/2019
Revenue	403.43B	359.05B	308.95B	276.71B	263.97B	238.23B	231.05B	214.32B
Cost of Goods Sold	388.88B	346.57B	296.75B	264.84B	251.32B	226.65B	219.65B	203.56B
Gross Profit	14.55B	12.48B	12.20B	11.87B	12.65B	11.58B	11.40B	10.76B
Gross Profit Margin	3.6%	3.5%	3.9%	4.3%	4.8%	4.9%	4.9%	5.0%
Total Operating Expenses	8.10B	8.11B	8.28B	7.42B	9.93B	8.07B	8.39B	7.68B
Research & Development	103.00M	91.00M	77.00M	89.00M	70.00M	74.00M	96.00M	71.00M
Selling, General & Administrative	-8.10B	8.02B	8.20B	7.33B	9.86B	8.00B	8.29B	7.61B
Operating Income (EBIT)	6.45B	4.37B	3.93B	4.45B	2.72B	3.51B	3.01B	3.08B
Operating Margin	1.6%	1.2%	1.3%	1.6%	1.0%	1.5%	1.3%	1.4%
Income Before Tax (EBT)	6.20B	4.36B	3.79B	4.63B	1.93B	-5.03B	1.14B	610.00M
Interest Income	179.00M	173.00M	118.00M	107.00M	10.00M	12.00M	49.00M	39.00M
Interest Expense	247.00M	256.00M	243.00M	248.00M	178.00M	217.00M	249.00M	264.00M
Other Income/Expense	-253.00M	-13.00M	-138.00M	177.00M	-795.00M	-8.54B	-1.87B	-2.47B
Net Income	4.76B	3.29B	3.00B	3.56B	1.11B	-4.54B	900.00M	34.00M
Income Tax Expense	1.10B	878.00M	629.00M	905.00M	636.00M	-695.00M	18.00M	356.00M
Net Profit Margin	1.2%	0.9%	1.0%	1.3%	0.4%	-1.9%	0.4%	0.0%
EBITDA	7.18B	5.01B	4.56B	5.31B	3.72B	4.73B	3.93B	4.03B
EBITDA Margin	1.8%	1.4%	1.5%	1.9%	1.4%	2.0%	1.7%	1.9%
Depreciation & Amortization	729.00M	636.00M	635.00M	857.00M	1.00B	1.22B	922.00M	949.00M
EPS Basic	38.55	25.86	22.54	25.23	7.31	-27.02	4.97	0.17
EPS Diluted	38.38	25.72	22.39	25.04	7.23	-27.02	4.95	0.17
Shares Outstanding	123.60M	127.40M	133.20M	141.10M	152.30M	160.60M	181.00M	196.30M
Diluted Shares Outstanding	124.10M	128.10M	134.10M	142.20M	154.10M	160.60M	182.00M	197.30M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.